Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $12,885 | 2 | 86.3% |
| Travel and Lodging | $1,345 | 6 | 9.0% |
| Food and Beverage | $695.16 | 11 | 4.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11,735 | 15 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $3,125 | 1 | $0 (2022) |
| ABBVIE INC. | $33.45 | 1 | $0 (2024) |
| Misonix Inc | $21.05 | 1 | $0 (2020) |
| STRATA Skin Sciences, Inc. | $10.62 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $33.45 | 1 | ABBVIE INC. ($33.45) |
| 2023 | $11,735 | 15 | Merck Sharp & Dohme LLC ($11,735) |
| 2022 | $3,125 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($3,125) |
| 2020 | $21.05 | 1 | Misonix Inc ($21.05) |
| 2017 | $10.62 | 1 | STRATA Skin Sciences, Inc. ($10.62) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.45 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $9,760.00 | General |
| 10/04/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 09/22/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $64.99 | General |
| 09/22/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $55.00 | General |
| 09/22/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 09/21/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $349.00 | General |
| 09/21/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $171.78 | General |
| 09/21/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 09/21/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $64.99 | General |
| 09/21/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $59.99 | General |
| 09/21/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $55.00 | General |
| 09/20/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $349.00 | General |
| 09/20/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $171.78 | General |
| 09/20/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $153.33 | General |
| 09/20/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $150.07 | General |
| 08/30/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,125.00 | General |
| 04/30/2020 | Misonix Inc | — | Food and Beverage | In-kind items and services | $21.05 | General |
| 07/06/2017 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: Dermatological Psoriasis and Vitiligo Treatment | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 163 | 374 | $146,222 | $42,742 |
| 2022 | 6 | 155 | 378 | $98,922 | $33,283 |
| 2021 | 4 | 140 | 273 | $73,349 | $24,810 |
| 2020 | 5 | 144 | 225 | $61,604 | $16,011 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2023 | 24 | 184 | $69,552 | $16,860 | 24.2% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 22 | 41 | $24,723 | $12,394 | 50.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 74 | $25,456 | $7,220 | 28.4% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 21 | 29 | $13,804 | $3,183 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 33 | $7,656 | $2,185 | 28.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 11 | 13 | $5,031 | $900.24 | 17.9% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2022 | 28 | 216 | $50,664 | $20,901 | 41.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 72 | $24,768 | $6,699 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 45 | $10,440 | $2,840 | 27.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 18 | 19 | $7,353 | $1,379 | 18.8% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 11 | $3,597 | $888.67 | 24.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 15 | $2,100 | $574.64 | 27.4% |
| 96910 | Skin application of tar and ultraviolet b or petrolatum and ultraviolet b | Office | 2021 | 22 | 122 | $25,620 | $12,135 | 47.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 51 | 76 | $26,144 | $7,067 | 27.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 48 | $11,136 | $3,499 | 31.4% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 27 | 27 | $10,449 | $2,109 | 20.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 59 | 82 | $28,208 | $6,282 | 22.3% |
| 96910 | Skin application of tar and ultraviolet b or petrolatum and ultraviolet b | Office | 2020 | 18 | 64 | $13,440 | $5,503 | 40.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 43 | $9,976 | $2,264 | 22.7% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 19 | 20 | $7,740 | $1,445 | 18.7% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 15 | 16 | $2,240 | $517.00 | 23.1% |
About Dr. Heidi Jacobe, M.D
Dr. Heidi Jacobe, M.D is a Dermatology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225097538.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Heidi Jacobe, M.D has received a total of $14,925 in payments from pharmaceutical and medical device companies, with $33.45 received in 2024. These payments were reported across 19 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($12,885).
As a Medicare-enrolled provider, Jacobe has provided services to 602 Medicare beneficiaries, totaling 1,250 services with total Medicare billing of $116,846. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Dallas, TX
- Active Since 03/23/2006
- Last Updated 02/15/2011
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225097538
Products in Payments
- SKYRIZI (Biological) $33.45
- XTRAC (Device) $10.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Dallas
Dr. Jennifer Cather, M.d, M.D
Dermatology — Payments: $1.8M
Dr. Joseph Merola, M.d., M.m.sc, M.D., M.M.SC
Dermatology — Payments: $1.7M
Dr. Martin Menter, Md, MD
Dermatology — Payments: $1.1M
Dr. So Yeon Paek, M.d, M.D
Dermatology — Payments: $637,453
Dr. William Abramovits, M.d, M.D
Dermatology — Payments: $634,225
Dr. Ross Radusky, M.d, M.D
Dermatology — Payments: $598,043